Roche’s obesity drug boosts blood sugar control, drives 15.5 percent weight loss in mid-stage trial
GENEVA: Swiss drugmaker Roche said on Tuesday its experimental dual-acting obesity drug helped overweight or obese patients with type 2 diabetes lowe...